Showing results (121-130 of 132) with videos related to
Sort By:
Pageof 14
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 1, 2020
Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow studyLudovic Lhermitte, Sylvain Barreau, Daniela Morf, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple MyelomaJuan-Jose Garcés, Maria-Teresa Cedena, Noemi Puig, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2024
Early Detection of Cancer and Precancerous Lesions in Persons With HIV Through a Comprehensive Cancer Screening ProtocolFélix Gutiérrez, Leandro López, Carlos Galera, et al.Cancers|April 30, 2021
B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma PatientsRobéria Mendonça de Pontes, Juan Flores-Montero, Luzalba Sanoja-Flores, et al.Blood|April 28, 2016
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patientsBruno Paiva, Maria-Teresa Cedena, Noemi Puig, et al.Leukemia|October 10, 2019
Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease disseminationJuan-Jose Garcés, Michal Simicek, Marco Vicari, et al.The EMBO Journal|September 18, 2023
Infection and inflammation stimulate expansion of a CD74+ Paneth cell subset to regulate disease progressionIyshwarya Balasubramanian, Sheila Bandyopadhyay, Juan Flores, et al.Leukemia|June 2, 2020
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myelomaJuan-José Garcés, Gabriel Bretones, Leire Burgos, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 27, 2019
Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple MyelomaBruno Paiva, Noemi Puig, Maria-Teresa Cedena, et al.Blood|July 22, 2020
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myelomaIbai Goicoechea, Noemi Puig, Maria-Teresa Cedena, et al.Pageof 14